Newronika logo  Building Neural Devices

Building Neural Devices

We transform research into clinical therapy

Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. ​
We are a multidisciplinary team formed from neuroscience research groups.  We involve scientists in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.

Shareholders

2 Public Institutions
4 Venture Capital Firms

The 13 Founders from Polyclinic and University of Milan are Neurosurgeons, Neurologists, Bioengineers, Neuropsychologists, Biotechnologist, Neurophysiology Technicians.



News room
NEURAL IMPLANT PODCAST
Lothar Krinke on adaptive Deep Brain Stimulation at Newronika
DEC 10,2022
LIFE SCIENCE INTELLIGENCE
Lothar Krinke, Newronika - Studio Interview | LSI Europe ‘22 - CEO, Lothar Krinke and Newronika are developing AlphaDBS, a closed-loop deep brain neuromodulation system for the management of symptoms due to Parkinson's disease.
SEPT 22, 2022
LIFE SCIENCE INTELLIGENCE
Lothar Krinke, Newronika - Neuromodulation System for Parkinson's | LSI Europe '22
SEPT 21, 2022
Lothar Krinke named CEO of Newronika starting the next phase of adaptive Neuromodulation product development.
MAY 25, 2022
Round d’investimento da 8,4 milioni per Newronika
Sept 27, 2019
PR NEWSWIRE
Newronika Raises an 8.4M EUR Series-A Round
Sep 26, 2019, 08:50 ET
Medtech, la startup italiana Newronika chiude un round da 8,4 milioni
Sept 26, 2019
BORSA ITALIANA
NEWRONIKA: COMPLETA NUOVO ROUND INVESTIMENTI DA 8,4 MLN
Sept 25, 2019
Eight-hours adaptive deep brain stimulation in patients with Parkinson disease
13/03/2018
1.7 million for startup that fights Parkinson's
14/06/2016
Neuromodulation Therapy Developer Newronika Raises €1.7M in Venture Capital
14/06/2016
Innogest, Intesa Sanpaolo and F3F invest 1.7 million in Newronika
14/06/2016
Intesa Sanpaolo: In the pool a loan of 1.7 mln to Newronika
14/06/2016
È italiano il primo pacemaker intelligente per il Parkinson
02/12/2011
Innogest and Intesa invest 1.7M in Newronika (Deep Brain Stimulation)
14/06/2016
Intesa Sanpaolo: Atlante Ventures co-invest in Newronika
14/06/2016
È italiano il primo pacemaker intelligente per il Parkinson
02/12/2011
Board of Directors
Lothar Krinke
CEO & Board Member
Lorenzo Rossi
CTO & Board Member
Sergio Barbieri
Board member
Claudio Giuliano
Board member
Claire Poulard
Board Member
Carlo Sanfilippo
Board member
Scientific Board
Alberto Priori
Chair
Guglielmo Foffani
Member
Andrès Lozano
Member
Sara Marceglia
Member
Elena Moro
Member
Jens Volkmann
Member
Ali Sarem-Aslani
Scientific Advisory Board Coordinator
Team
Chiara Giuditta Motta
Accounting
Chiara Petrangeli
Lead Development
aDBS technology development
Costanza Conti
Clinical Affairs Manager
Regulatory and Clinical Investigation
Daniel Senderowicz
Head of ASIC Dev
aDBS technology development
Ernesto Della Torre
Production
aDBS technology development
Fabio Grisoni
Chief Strategic Officer
marketing and sales
Francesca Brambilla
Accounting
Financial Accounting
Jacopo Cavagnoli
Industrial Designer
Wearable Devices & UX
Luca Cavagnoli
Production
aDBS technology development
Marco Prenassi
App and Wearable Devices
Webbiobank
Mattia Arlotti
VP - Engineering and New Product Development
aDBS technology development
Mirela Presecan
Marketing & Sales Coordinator
marketing and sales
Pietro Zacchera
Quality Manager
Regulatory and Clinical Investigation
Roberta Ferrucci
Clinical Advisor
Regulatory and Clinical Investigation
Sergio Sinisi
ASIC Designer
aDBS technology development
Silvia Bracchi
Accounting
Marketing & Sales
Valentina Cossa
Lead Technician
aDBS technology development
Vanessa Aloia
Firmware
aDBS technology development
Researcher collaborations are welcome!

Close loop can work in different area and application, please help us to look forward.
Collaboration is one of our main values, if interested feel free to get in touch.

CONTACT US!
key
login incorrect
login temporarily blocked. Retry in a bit.